Amniotic fluid levels of dimeric inhibins, pro-αC inhibin, activin A and follistatin in Down's syndrome

Clinical Endocrinology

Volumn 50, Issue 5, 1999, Pages 669-673

  Wallace, Euan M ^a   D'Antona, Donato ^a   Shearing, Catherine ^b   Evans, Lee W ^c   Thirunavukarasu, Prema ^a   Ashby, J Peter ^b   Shade, Mary ^d   Groome, Nigel P ^c  

^a MONASH UNIVERSITY   (Australia)

^b NHS LOTHIAN   (United Kingdom)

^c OXFORD BROOKES UNIVERSITY   (United Kingdom)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; FOLLISTATIN; INHIBIN;

AMNION FLUID; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE METABOLISM; HORMONE RELEASE; HUMAN; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

ACTIVINS; AMNIOTIC FLUID; CASE-CONTROL STUDIES; DOWN SYNDROME; FEMALE; FETAL DISEASES; FOLLISTATIN; GLYCOPROTEINS; HUMANS; INHIBINS; PEPTIDES; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; PROSTATIC SECRETORY PROTEINS; PROTEIN PRECURSORS; STATISTICS, NONPARAMETRIC;

EID: 0032931820     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00716.x     Document Type: Article

References (26)

1. Aitken D.A., Wallace E.M., Crossley J.A., Swanston I.A., van Pareren U., van Maarle M., Groome N.P., Maeri J.M. & Connor J.M. (1996) Dimeric inhibin-A as a marker for Down's syndrome in early pregnancy. New England Journal of Medicine, 334, 1321-1326.
2. Cuckle H.S., Wald N.J., Lindenbaum R.H. & Johnsson J. (1985) Amniotic fluid AFP levels and Down's syndrome. Lancet, 1, 290-291.
3. Cuckle H.S., Wald N.J., Densem J.W., Canick J. & Abell K.B. (1991) Second trimester amniotic fluid oestriol, dehydroepiandrosterone sulphate, and human chorionic gonadotrophin levels in Down's syndrome. British Journal of Obstetrics and Gynaecology, 98, 1160-1162.
4. Cuckle H.S., Holding S., Jones R., Groome N.P. & Wallace E.M. (1996) Combining inhibin with existing second trimester markers in maternal serum screening for Down's syndrome, Prenantal Diagnosis, 16 1095-1101.
5. de Kretser D.M., Foulds L.M., Hancock M. & Robertson D.M. (1994) Partial characterisation of inhibin, activin and follistatin in the term human placenta. Journal of Clinical Endocrinology and Metabolism, 79, 502-507.
6. Evans L.W., Muttukrishna S. & Groome N.P. (1998) Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin. Journal of Endocrinology, 156, 275-282.
7. Groome N.P. & O'Brien M. (1993) Two-site immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach. Journal of Immunological Methods, 165, 167-176.
8. Groome N.P., Illingworth P.J., O'Brien M., Priddle J., Weaver K, & McNeilly A.S. (1995) Quantification of inhibin pro-αC containing forms in human serum by a new ultrasensitive two-site enzymelinked immuosorbent assay. Journal of Clinical Endocrinology and Metabolism, 80, 2926-2932.
9. Groome N.P., Illingworth P.J., O'Brien M., Pai R., Rodger F.E., Mather J. & McNeilly A.S. (1996) Measurement of dimeric inhibin-B throughout the human menstrual cycle. Journal of Clinical Endocrinology and Metabolism, 81, 1401-1405.
10. Knight P.G., Muttukrishna S. & Groome N.P. (1996) Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid, Journal of Endocrinology, 148, 267-279.
11. Lambert-Messerlian G.M., Canick J.A., Palomaki G.E. & Schneyer A.L. (1996) Second trimester levels of maternal serum inhibin A. total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy. Journal of Medical Screening. 3, 58-62.
12. Lambert-Messerlian G.M., Luisi S., Florio P., Mazza V., Canick J.A. & Petraglia F. (1998) Second trimester levels of maternal serum total activin A and placental inhibin/activin α and βA subunil messenger ribonucleic acids in Down syndrome pregnancy. European Journal of Endocrinology, 138, 425-429.
13. Muttukrishna S., George L., Fowler P.A., Groome N.P. & Knoght P.G. (1995) Measurement of serum concentrations of inhibin-A (α-βA dimer) during human pregnancy. Clinical Endocrinology. 42, 391-397.
14. Petraglia F., Gallinelli A., Grande A., Florio P., Ferrari S., Genazzani A.R., Ling N. & de Paolo L.V. (1994) Local production and action of follistatin in human placenta. Journal of Clinical Endocrinology and Metabolism, 78, 205-210.
15. Qu J. & Thomas K. (1995) Inhibin and activin production in human placenta. Endocrime Reviews, 16, 485-507.
16. Riley S.C., Wathen N., Chard T., Groome N.P. & Wallace E.M. (1996) Inhibins in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Human Reproduction, 11, 2722-2776.
17. Riley S.C., Balfour C., Wathen N.C., Chard T., Groome N.P, & Wallace E.M. (1998) Follistatin and activin-A in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Human Reproduction, 13, 2624-2628.
18. Robertson D.M., Cahir N., Findlay J.K., Burger H.G. & Groome N.P. (1997) The biological and immunologieal characterisation in inhibin A and B forms in human follicular fluid and plasma. Journal of Clinical Endocrinology and Metabolism, 82, 889-896.
19. Spencer K., Muller F. & Aitken D.A, (1997) Biochemical markers of trisomy 21 in amniotic fluid. Prenatal Diagnosis, 17, 31-37.
20. Ueno N., Ling N., Ying S-Y, Esch F., Shimasaki S. & Guillemin R. (1987) Isolation and partial characterisation of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proceedings of the National Academy of Sciences (USA), 84, 8282-8286.
21. Wallace E.M. & Healy D.L. (1996) Inhibin and acitivins: roles in clinical practice. British Journal of Obstetrics and Gynaecology, 103, 945-956.
22. Wallace E.M., Swanston I.A., McNeilly A.S., Ashby J.P., Blundell G., Calder A.A. & Groome N.P. (1996) Second trimester screening for Down's syndrome using maternal serum dimeric inhibin-A. Clinical Endocrinology, 44, 17-21.
23. Wallace E.M., Riley S.C., Crossley J.A., Ritoe S.C., Horne A., Shade M., Ellis P., Aitken D.A. & Groome N.P. (1997a) Dimeric inhibins in amniotic fluid, maternal serum and fetal serum in human pregnancy. Journal of Clinical Endocrinology and Metabolism, 82, 218-222.
24. Wallace E.M., Crossley J.A., Groome N.P. & Aitken D.A. (1997b) Inhibin-A in amniotic fluid in chromosomally normal and Down's syndrome pregnancies. Journal of Endocrinology, 152, 109-112.
25. Wallace E.M., Crossley J.A., Riley S.C., Balfour C., Groome N.P. & Aitken D.A. (1998) Inhibin-B and pro-αC containing inhibins in amniotic fluid from chromosomally normal and Down's syndrome pregnancies. Prenatal Diagnosis, 18, 213-217.
26. Woodruff T.K., Sluss P., Wang E, Janssen I. & Mersol-Barg M.S. (1997) Activin A and follistatin are dynamically regulated during human pregnancy. Journal of Endocrinology, 152, 167-174.